Cargando…

MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma

BACKGROUND: Urothelial carcinoma (UC) is the most common cancer affecting the urinary system, worldwide. Lack of accurate early detection tools entails delayed diagnosis, precluding more efficient and timely treatment. In a previous study, we found that miR-129-2 and miR-663a were differentially met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Padrão, Nuno André, Monteiro-Reis, Sara, Torres-Ferreira, Jorge, Antunes, Luís, Leça, Luís, Montezuma, Diana, Ramalho-Carvalho, João, Dias, Paula C, Monteiro, Paula, Oliveira, Jorge, Henrique, Rui, Jerónimo, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344289/ https://www.ncbi.nlm.nih.gov/pubmed/28081549 http://dx.doi.org/10.1038/bjc.2016.454

Ejemplares similares

MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis
por: Silva-Santos, R M, et al.
Publicado: (2013)

A Multiplex Test Assessing MiR663a(me) and VIM(me) in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions
por: Monteiro-Reis, Sara, et al.
Publicado: (2020)

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance
por: Sapre, Nikhil, et al.
Publicado: (2016)

Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma
por: Wallard, M J, et al.
Publicado: (2006)

Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
por: Shimwell, N J, et al.
Publicado: (2013)

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014)

MT1-MMP regulates urothelial cell invasion via transcriptional regulation of Dickkopf-3
por: Saeb-Parsy, K, et al.
Publicado: (2008)

Expression of MAGE-A3, NY-ESO-1, LAGE-1 and PRAME in urothelial carcinoma
por: Dyrskjøt, L, et al.
Publicado: (2012)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM
por: Bryan, R T, et al.
Publicado: (2015)

Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted
por: Langbein, S, et al.
Publicado: (2006)

Expression of parvin-β is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract
por: Wu, C-F, et al.
Publicado: (2010)

Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
por: Yoshimine, S, et al.
Publicado: (2013)

Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract
por: Douglas, J, et al.
Publicado: (2014)

Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
por: Dalpiaz, O, et al.
Publicado: (2014)

Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control
por: Seidel, A, et al.
Publicado: (2006)

Accurate and rapid novel genetic diagnosis for detection of sentinel lymph node metastasis in breast cancer patients
por: Iinuma, H, et al.
Publicado: (2012)

Accurate staging of axillary lymph nodes from breast cancer patients using a novel molecular method
por: Osako, T, et al.
Publicado: (2011)

Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma
por: Konishi, H, et al.
Publicado: (2012)

Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signature
por: Fukumoto, I, et al.
Publicado: (2014)

Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c
por: Nygren, M K, et al.
Publicado: (2014)

microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma
por: Yau, T O, et al.
Publicado: (2014)

The functional significance of microRNA-145 in prostate cancer
por: Zaman, M S, et al.
Publicado: (2010)

Circulating microRNAs in plasma of patients with gastric cancers
por: Tsujiura, M, et al.
Publicado: (2010)

Identification of serum microRNA profiles in colon cancer
por: Hofsli, E, et al.
Publicado: (2013)

MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors
por: Torres-Ferreira, Jorge, et al.
Publicado: (2017)

MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways
por: Fukumoto, I, et al.
Publicado: (2015)

One-step nucleic acid amplification assay is an accurate technique for sentinel lymph node biopsy of breast cancer patients: a meta-analysis
por: Shi, Fang, et al.
Publicado: (2017)

Changes in circulating microRNA levels associated with prostate cancer
por: Bryant, R J, et al.
Publicado: (2012)

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker
por: Goto, Yusuke, et al.
Publicado: (2015)

Mcm2 predicts recurrence hazard in stage Ta/T1 bladder cancer more accurately than CK20, Ki67 and histological grade
por: Burger, M, et al.
Publicado: (2007)

Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy
por: Dunn, J M, et al.
Publicado: (2010)

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
por: Komatsu, S, et al.
Publicado: (2011)

MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas
por: Missiaglia, E, et al.
Publicado: (2010)

MicroRNA profiles classify papillary renal cell carcinoma subtypes
por: Wach, S, et al.
Publicado: (2013)

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
por: Jones, C I, et al.
Publicado: (2012)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer
por: Miah, S, et al.
Publicado: (2012)

MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer
por: Ng, E K O, et al.
Publicado: (2009)

ING1b-inducible microRNA203 inhibits cell proliferation
por: Chen, J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_peuprnr08fbo0ppqtd1k5s49c0